Clinical trial

Randomized Trial to Assess the Impact of a Screening Program on Upper…

NCT00359645 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Completed

Key facts

NCT number NCT00359645
Title Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
Official title DEPISTORL - THANCS (Trial of Head And Neck Cancer Screening) Randomized Multicenter Trial to Assess the Impact of a Screening Program for Heavy Alcohol Drinkers and Smokers Treated in Alcohol Addiction Clinics on Upper Aerodigestive Tract Cancer Mortality.
Lead sponsor Gustave Roussy, Cancer Campus, Grand Paris, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Pharynx Cancer, Larynx Cancer, Oral Cavity Cancer, Oesophageal Cancer
Intervention type Procedure
Interventions Screening by head and neck clinical examination with a fiberoptic nasolaryngoscopy and an oesopharyngeal brush biopsy annually during 3 years
Enrollment 1,993
Start date Jun 21, 2006
Primary completion Dec 18, 2015
Completion Dec 18, 2015
First posted Aug 2, 2006
Last update posted May 16, 2017
Countries France

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies